Works matching AU Si Young Kim


Results: 51
    1
    2

    Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

    Published in:
    Oncologist, 2015, v. 20, n. 12, p. 1440, doi. 10.1634/theoncologist.2015-0128
    By:
    • Kim, Hyo Jung;
    • Shin, Sang Won;
    • Song, Eun‐Kee;
    • Lee, Na‐Ri;
    • Kim, Jun Suk;
    • Ahn, Jin Seok;
    • Yun, Hwan‐Jung;
    • Cho, Yo‐Han;
    • Park, Keon Uk;
    • Kim, Si‐Young;
    • Jang, Joung Soon;
    • Kim, Sang‐We;
    • Lee, Hyun Woo;
    • Lee, Se Ryeon;
    • Kim, Yang Soo;
    • Lee, Soon Nam;
    • Ko, Yoon Ho;
    • Kim, Hwa Jung;
    • Kang, Jin‐Hyoung
    Publication type:
    Article
    3

    A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 523, doi. 10.4143/crt.2022.1360
    By:
    • Dae-Won Lee;
    • Bhumsuk Keam;
    • Keun Seok Lee;
    • Jin-Hee Ahn;
    • Joohyuk Sohn;
    • Jin Seok Ahn;
    • Moon Hee Lee;
    • Jee Hyun Kim;
    • Kyung Eun Lee;
    • Hyo Jung Kim;
    • Si-Young Kim;
    • Yeon Hee Park;
    • Chan-Young Ock;
    • Kyung-Hun Lee;
    • Sae-Won Han;
    • Sung-Bae Kim;
    • Young Hyuck Im;
    • Hyun Cheol Chung;
    • Do-Youn Oh;
    • Seock-Ah Im
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

    Published in:
    2016
    By:
    • Oh, Do-Youn;
    • Im, Seock-Ah;
    • Lee, Ki;
    • Han, Hye;
    • Park, Jae;
    • Choi, Young;
    • Kim, Hee-Jun;
    • Jung, Kyung;
    • Kim, Si-Young;
    • Kim, Ji-Yeon;
    • Lee, Moon;
    • Lim, Joo;
    • Park, Keon;
    • Park, In;
    • Cho, Eun;
    • Yoon, So;
    • Kim, Jee;
    • Choi, In;
    • Lee, Ki Hyeong;
    • Lee, Moon Hee
    Publication type:
    journal article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer.

    Published in:
    Psycho-Oncology, 2014, v. 23, n. 12, p. 1423, doi. 10.1002/pon.3582
    By:
    • Yun, Young Ho;
    • Sim, Jin Ah;
    • Jung, Ju Youn;
    • Noh, Dong‐Young;
    • Lee, Eun Sook;
    • Kim, Young Woo;
    • Oh, Jae Hwan;
    • Ro, Jung Sil;
    • Park, Sang Yoon;
    • Park, Sang Jae;
    • Cho, Kwan Ho;
    • Chang, Yoon Jung;
    • Bae, Yeon Min;
    • Kim, Si Young;
    • Jung, Kyung Hae;
    • Zo, Zae Ill;
    • Lim, Jae‐Young;
    • Lee, Soon Nam
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.

    Published in:
    Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
    By:
    • Satoh, Taroh;
    • Lee, Kyung;
    • Rha, Sun;
    • Sasaki, Yasutsuna;
    • Park, Se;
    • Komatsu, Yoshito;
    • Yasui, Hirofumi;
    • Kim, Tae-You;
    • Yamaguchi, Kensei;
    • Fuse, Nozomu;
    • Yamada, Yasuhide;
    • Ura, Takashi;
    • Kim, Si-Young;
    • Munakata, Masaki;
    • Saitoh, Soh;
    • Nishio, Kazuto;
    • Morita, Satoshi;
    • Yamamoto, Eriko;
    • Zhang, Qingwei;
    • Kim, Jung-mi
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50